Flow Cytometry Services Market | Asia-Pacific Region has Significant Growth Opportunities

According to the latest research by InsightAce Analytic, the global Flow Cytometry Services market is valued at US$ 876.33 Million in 2021, and it is expected to reach US$ 1,501.02 Million by 2030, with a CAGR of 6.21% during the forecast period of 2022-2030.

Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1209

Flow cytometry is an effective laboratory technique used to analyze the cell population in heterogenous suspension based on their physical and fluorescence characteristics. This is achieved using instrumentation that directs a single stream of cells past a light source and measures scattered and emitted energy in various wavelengths. This scattered light is responsible for determining cells' size and intracellular complexity. The tool analyses the data at the thousand particles per second quantified and plotted digitally.

Researchers use fluorescent molecules with different excitation and emission properties to be united, detected, and differentiated to provide compound data from a single cell. These fluorescent molecules may be stuck to antibodies targeting specific proteins or protein modifications, or they may be dyes that directly combine with cellular components. The technique is mainly used to research and diagnose diseases like cancer and AIDS. Many articles and research papers have been published regarding the connection between HIV and the flow cytometry technique. Flow Cytometry services consist of specimen processing, experimental design, acquisition and data analysis to strengthen biotech, pharmaceutical companies and researchers in drug development.

Request for ToC/Proposal: https://www.insightaceanalytic.com/report/global-flow-cytometry-services-market/1209

The market growth can be attributed to diminishing restrictions on commercial activities like transportation, packaging, and manufacturing, which were operational challenges earlier in the pandemic. The initiatives undertaken by governments and global health organizations to increase awareness about cancer and HIV infections will amplify the rate of diagnosis and hence the public and private diagnosis centres. Rapidly enhancing the rate of pre-clinical trials is one of the foremost drivers of this service market as the flow cytometry required from the beginning of the research and development of the drug. Regionally, The Asia-Pacific region has significant development opportunities due to less stringent regulations and data requirements than other areas.

Key market players operating in the Flow Cytometry Services market include FlowMetric Life Sciences, Flow Contract Sites Laboratory, Bio-Legend, Q2 Solutions, ProImmune, MLM Medical Labs, Unilabs, Firalis, Agilex Biolabs, ACROBIOsystems, Ardena, Life Science Research, Cell flow cytometry, Research Lab Services, Fluorescence, CHOP Research Institute, Bio-Rad Laboratories, Plant Cytometry services, Aurelia Bioscience, Proimmune, Sphere Fluidics Limited, Iconplc, Beakman Coulter, IBR Inc., FACS Servies, Flow Contract side Laboratory, Rockland-inc, NeoGenomics, Charles River Laboratories, ProMab, RayBiotech, Creative Proteomics, ACM Global Laboratories, Covance, ReachBio, Mdbiosciences, CSI Laboratories, Other Prominent Players.

Key developments in the market:

• In Feb 2022, Cytognos has acquired by BD (Becton, Dickinson and Company). Through this acquisition, Cytognos' key products increase BD's broad portfolio of diagnostic and research solutions for certain cancers that use flow cytometry as the primary means of discovery, diagnosis and understanding, including lymphoma, leukaemia and multiple myeloma.

• In Feb 2022, KCAS has acquired FlowMetric, LLC. KCAS has made major investments, including a nearly completed 70,000-square-foot new facility in Kansas City; continuing to attract the industry's top scientific expertise and focusing on excellent customer service, and increasing globalization through further acquisitions. The acquisition of FlowMetric provides additional operational support to the merged company's clients, allowing them to fulfil rising demand and industry demands.

• In Jan 2022, Insightful Science announced acquisition of Omiq Inc. Insightful Science's flow cytometry software portfolio now includes OMIQ in addition to Cytapex Bioinformatics and FCS Express. GraphPad Prism, SnapGene, Geneious, Dotmatics, LabArchives, Protein Metrics, and nQuery, among other top products, are part of an expanding range of scientific R&D tools.

• In June 2020, The XF-1600* flow cytometer from Sysmex America, Inc. is now available. For a wide range of applications, the fully automated XF-1600TM provides laboratories with increased flexibility and efficiency.

Curious about Report Details @ Request for ToC/Proposal: https://www.insightaceanalytic.com/report/global-flow-cytometry-services-market/1209

Market Segments:

Global Flow Cytometry Services Market, by Accreditation Types, 2019-2030 (Value US$ Mn)
• Government
• Third-Party Accreditations
Global Flow Cytometry Services Market, by Services Types, 2019-2030 (Value US$ Mn)
• Type of General Flow Cytometric Services
o Assay Development
o Consumables Manufacturing
• Type of Analysis based Flow Cytometric Services
o PBMC Analysis
o Whole Blood Cells Analysis
o Bone Marrow Aspirate Analysis
o Stem Cells Analysis
o Rare Cells Detection
o Cell Profiling and Subsetting
o Intracellular Staining
• Other types of Flow Cytometric Services

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products.

Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com

This release was published on openPR.